Drugs & Therapy Perspectives

, Volume 20, Issue 2, pp 5–7 | Cite as

Dutasteride: profile report

  • J. Curtis Nickel
  • Gerald L. Andriole
Drugs and Profile Reports
  • 18 Downloads

References

  1. 1.
    Evans HC, Goa KL. Dutasteride. Drugs Aging 2003; 20 (12): 905–16.PubMedCrossRefGoogle Scholar
  2. 2.
    Nickel JC. Dutasteride: a viewpoint. Drugs Aging 2003; 20 (12): 917–8.CrossRefGoogle Scholar
  3. 3.
    Andriole GL. Dutasteride: a viewpoint. Drugs Aging 2003; 20 (12): 918.CrossRefGoogle Scholar
  4. 4.
    Roehrborn CG, Boyle P, Nickel JC, et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. ARIA 3001, ARIA 3002 and ARIA 3003 study investigators. Urology 2002 Sep; 60: 434–41.PubMedCrossRefGoogle Scholar
  5. 5.
    Glaxo Smith Kline. New data evaluating four years of treatment with Avodart (dutasteride) support long-term efficacy and tolerability in men with BPH [online]. Available from URL: http://www.gsk.com [Accessed 2003 Apr 2]
  6. 6.
    Barkin J, Guimaraes M, Do Castelo V, et al. Dutasteride provides sustained symptom relief following short term combination treatment with tamsulosin [abstract no. 1481]. J Urol 2002 Apr; 167 Suppl.: 372Google Scholar
  7. 7.
    Poole RM. Dutasteride: rapid benefit in patients with BPH. Inpharma 2002 Mar 30; 1331: 9–10.Google Scholar
  8. 8.
    Roehrborn CG, Andriole G, Nickel C, et al. Effect of dutasteride, a novel dual 5-alpha-reductase inhibitor, on BPH related signs and symptoms [abstract no. 1043]. J Urol 2002 Apr; 167 (4 Suppl.): 265Google Scholar
  9. 9.
    Carson C, Harkaway R, Marks L, et al. Effect of maximal dihydrotestosterone suppression with dutasteride on sexual function and gynecomastia [abstract no. 1790]. J Urol 2003; 169 (4 Suppl.): 478.Google Scholar
  10. 10.
    McConnell JD. The long term effects of medical therapy on the progresssion of BPH: results from the MTOPS trial. MTOPS Steering Committee [abstract no. 1042]. J Urol 2002; 167 (4 Suppl.): 265.Google Scholar
  11. 11.
    Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349 (3): 215–24.PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • J. Curtis Nickel
    • 1
  • Gerald L. Andriole
    • 2
  1. 1.Queen’s University, Kingston General HospitalKingstonCanada
  2. 2.Division of UrologyWashington University School of MedicineSt LouisUSA

Personalised recommendations